标题
In cancer, all roads lead to NADPH
作者
关键词
NAD, NADPH, NAD kinase, Calmodulin, ROS
出版物
PHARMACOLOGY & THERAPEUTICS
Volume 226, Issue -, Pages 107864
出版商
Elsevier BV
发表日期
2021-04-22
DOI
10.1016/j.pharmthera.2021.107864
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Beyond Energy Metabolism: Exploiting the Additional Roles of NAMPT for Cancer Therapy
- (2020) Christine M. Heske Frontiers in Oncology
- NAD- and NADPH-Contributing Enzymes as Therapeutic Targets in Cancer: An Overview
- (2020) Alvinsyah Adhityo Pramono et al. Biomolecules
- A small molecule G6PD inhibitor reveals immune dependence on pentose phosphate pathway
- (2020) Jonathan M. Ghergurovich et al. Nature Chemical Biology
- BRD4 inhibition sensitizes renal cell carcinoma cells to the PI3K/mTOR dual inhibitor VS-5584
- (2020) Ming Xu et al. Aging-US
- Hexavalent chromium-induced apoptosis in Hep3B cells is accompanied by calcium overload, mitochondrial damage, and AIF translocation
- (2020) XiangFei Zhang et al. ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
- NADP+ is an endogenous PARP inhibitor in DNA damage response and tumor suppression
- (2019) Chunjing Bian et al. Nature Communications
- Direct stimulation of NADP+ synthesis through Akt-mediated phosphorylation of NAD kinase
- (2019) Gerta Hoxhaj et al. SCIENCE
- Consequences of IDH1/2 Mutations in Gliomas and an Assessment of Inhibitors Targeting Mutated IDH Proteins
- (2019) Bozena Kaminska et al. MOLECULES
- Pim-1 inhibitor SMI-4a suppresses tumor growth in non-small cell lung cancer via PI3K/AKT/mTOR pathway
- (2019) Wenjie Jiang et al. OncoTargets and Therapy
- Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
- (2019) Elisa Bergaggio et al. Cancers
- Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases
- (2019) Franziska Maria Ippen et al. NEURO-ONCOLOGY
- NAD-Biosynthetic and Consuming Enzymes as Central Players of Metabolic Regulation of Innate and Adaptive Immune Responses in Cancer
- (2019) Valentina Audrito et al. Frontiers in Immunology
- Calmodulin Is the Fundamental Regulator of NADK-Mediated NAD Signaling in Plants
- (2019) Li Tai et al. Frontiers in Plant Science
- The Regulatory Role of NAD in Human and Animal Cells
- (2018) V. A. Kulikova et al. BIOCHEMISTRY-MOSCOW
- Wild-type and mutated IDH1/2 enzymes and therapy responses
- (2018) Remco J. Molenaar et al. ONCOGENE
- Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
- (2018) Dongshao Chen et al. Cell Death & Disease
- Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines
- (2018) Malgorzata Tyszka-Czochara et al. Nutrients
- NAD Kinases: Metabolic Targets Controlling Redox Co-enzymes and Reducing Power Partitioning in Plant Stress and Development
- (2018) Bin-Bin Li et al. Frontiers in Plant Science
- TAp73-induced phosphofructokinase-1 transcription promotes the Warburg effect and enhances cell proliferation
- (2018) Le Li et al. Nature Communications
- NAD Metabolism in Cancer Therapeutics
- (2018) Keisuke Yaku et al. Frontiers in Oncology
- Niacin intake and risk of skin cancer in US women and men
- (2017) Sang Min Park et al. INTERNATIONAL JOURNAL OF CANCER
- Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells
- (2017) Angela M. Gocher et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma
- (2017) Elisabeth F.P. Peterse et al. MOLECULAR CANCER RESEARCH
- Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
- (2017) Jair Machado Espindola-Netto et al. Oncotarget
- NAD+ Kinase as a Therapeutic Target in Cancer
- (2016) P. M. Tedeschi et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Isocitrate Dehydrogenase Mutations in Cancer
- (2016) O. Clark et al. CLINICAL CANCER RESEARCH
- Functional annotation of rare gene aberration drivers of pancreatic cancer
- (2016) Yiu Huen Tsang et al. Nature Communications
- Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway
- (2016) Jun Feng et al. Biomed Research International
- Efficacy and Safety of APO866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma
- (2016) Simone M. Goldinger et al. JAMA Dermatology
- Increased reactive oxygen species production during reductive stress: The roles of mitochondrial glutathione and thioredoxin reductases
- (2015) Paavo Korge et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Calcium mobilizing second messengers derived from NAD
- (2015) Andreas H. Guse BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
- (2015) Kensuke Tateishi et al. CANCER CELL
- PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells
- (2015) Jiezhong Chen et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Niacin (Vitamin B3) Supplementation in Patients with Serotonin-Producing Neuroendocrine Tumor
- (2015) Grietje Bouma et al. NEUROENDOCRINOLOGY
- NAD kinase controls animal NADP biosynthesis and is modulated via evolutionarily divergent calmodulin-dependent mechanisms
- (2015) Nick R. Love et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model
- (2015) Giovanna Sociali et al. Oncotarget
- Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
- (2014) Krishna S. Tummala et al. CANCER CELL
- Synergy between the NAMPT Inhibitor GMX1777(8) and Pemetrexed in Non-Small Cell Lung Cancer Cells Is Mediated by PARP Activation and Enhanced NAD Consumption
- (2014) M. Chan et al. CANCER RESEARCH
- Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation
- (2013) Joshua T. Wilson-Grady et al. METHODS
- Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence
- (2013) Peng Jiang et al. NATURE
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- A systematic analysis of the PARP protein family identifies new functions critical for cell physiology
- (2013) Sejal Vyas et al. Nature Communications
- Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
- (2012) Ilirjana Bajrami et al. EMBO Molecular Medicine
- Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas
- (2011) UFFE HØGH OLESEN et al. APMIS
- p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
- (2011) Peng Jiang et al. NATURE CELL BIOLOGY
- Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells
- (2010) Gabriele Zoppoli et al. EXPERIMENTAL HEMATOLOGY
- Pak protein kinases and their role in cancer
- (2009) Bettina Dummler et al. CANCER AND METASTASIS REVIEWS
- Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
- (2009) Anne von Heideman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- NAD+/NADH and NADP+/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences
- (2007) Weihai Ying ANTIOXIDANTS & REDOX SIGNALING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now